Patents by Inventor Gila Moalem

Gila Moalem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7560102
    Abstract: Compositions and methods to promote nerve regeneration or to confer neuroprotection and prevent or inhibit neuronal degeneration within the nervous system, either the central nervous system or the peripheral nervous system, are provided. Treatment involves administering NS-specific activated T cells, or an NS-specific antigen or analog thereof, a peptide derived therefrom or an analog or derivative of said peptide, or a nucleotide sequence encoding such an antigen or peptide, or any combination thereof.
    Type: Grant
    Filed: March 29, 2004
    Date of Patent: July 14, 2009
    Assignee: Yeda Research and Development Co., Ltd
    Inventors: Michal Eisenbach-Schwartz, Ehud Hauben, Irun R. Cohen, Pierre Beserman, Alon Monsonego, Gila Moalem
  • Publication number: 20040253218
    Abstract: Compositions and methods to promote nerve regeneration or to confer neuroprotection and prevent or inhibit neuronal degeneration within the nervous system, either the central nervous system or the peripheral nervous system, are provided. Treatment involves administering NS-specific activated T cells, or an NS-specific antigen or analog thereof, a peptide derived therefrom or an analog or derivative of said peptide, or a nucleotide sequence encoding said antigen or peptide, or any combination thereof.
    Type: Application
    Filed: March 29, 2004
    Publication date: December 16, 2004
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
    Inventors: Michal Eisenbach-Schwartz, Ester Yoles, Ehud Hauben, Irun R. Cohen, Pierre Beserman, Alon Monsonego, Gila Moalem
  • Publication number: 20030108528
    Abstract: The present invention discloses compositions and methods for the treatment of injury or disease of the nervous system CNS. In a particular embodiment, the invention provides methods of treatment using non-recombinant activated antiself T-cells that recognize an antigen of the NS or a peptide derived therefrom or a derivative thereof to promote nerve regeneration or to prevent or inhibit axonal degeneration within the NS. The invention also provides methods of treatment using a NS-specific antigen or peptide derived therefrom or a derivative thereof or a nucleotide sequence encoding said antigen or peptide to promote nerve regeneration or to prevent or inhibit axonal degeneration in NS, i.e., the CNS and/or PNS. The NS-specific antiself activated T-cells may be administered alone or in combination with NS-specific antigen or peptide derived therefrom or a derivative thereof or a nucleotide sequence encoding said antigen or peptide or any combination thereof.
    Type: Application
    Filed: December 22, 1998
    Publication date: June 12, 2003
    Inventors: MICHAL EISENBACH-SCHWARTZ, IRUN R. COHEN, GILA MOALEM, PIERRE BESERMAN, ALON MONSONEGO
  • Publication number: 20020072493
    Abstract: Compositions and methods to promote nerve regeneration or to confer neuroprotection and prevent or inhibit neuronal degeneration within the nervous system, eiteher the central nervous system or the peripheral nervous system, are provided. Treatment involves administering NS-specific activated T cells, or an NS-specific antigen or analog thereof, a peptide derived therefrom or an analog or derivative of said peptide, or a nucleotide sequence encoding said antigen or peptide, or any combination thereof.
    Type: Application
    Filed: June 28, 2001
    Publication date: June 13, 2002
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Michal Eisenbach-Schwartz, Ehud Hauben, Irun R. Cohen, Pierre Beserman, Alon Mosonego, Gila Moalem